Karyopharm Therapeutics Inc. · NASDAQ:KPTI
Opaleye Management Inc.'s stake in Karyopharm Therapeutics Inc. fell to 2.67% (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 11, 2026
Opaleye Management Inc.'s stake in Karyopharm Therapeutics Inc. fell to 2.67%, 619,089 shares, as a passive investor on Mar 31, 2026. Filed May 11, 2026 (Schedule 13G/A).
- Stake
- 2.67%
- Shares
- 619,089
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Opaleye Management Inc. | 2.67% | 619,089 |
| Opaleye, L.P. | 2.67% | 619,089 |
| James Silverman | 2.67% | 619,089 |
Source
Related
- Karyopharm Therapeutics Inc.
- Opaleye Management Inc.
- Karyopharm Therapeutics Inc. shareholders
- Schedule 13G · Opaleye Management Inc. · Oct 17, 2025
- Form 4 · Abate Kristin · Oct 19, 2026
- Schedule 13G/A · Anders Hove · Oct 8, 2026
- Form 4 · Abate Kristin · Oct 2, 2026
- Schedule 13G/A · Anders Hove · Sep 25, 2026
- Schedule 13G/A · Anders Hove · Sep 25, 2026